日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Whole-genome landscapes of 1,364 breast cancers.

1364 例乳腺癌的全基因组图谱。

Kim Ryul, Yu Jonghan, Lim Joonoh, Oh Brian Baek-Lok, Nam Seok Jin, Kim Seok Won, Lee Jeong Eon, Chae Byung Joo, Kim Ji-Yeon, Park Ga Eun, Kang Bong Joo, Paik Pill Sun, Bae Soo Yeon, Yoon Chang Ik, Lee Young Joo, Kim Dooreh, Shin Kabsoo, Lee Ji Eun, Kang Jun, Lee Ahwon, Connolly-Strong Erin, Lee Sangmoon, Lee Bo Rahm, Lee Yuna, Yi Ki Jong, Kwon Young Oh, Chun In Hwan, Park Junggil, Kim Jihye, Choi Chahyun, Shin Jong Yeon, Lee Hyungjung, Kim Minji, Park Hansol, Jeong Ilecheon, Yi Boram, Lee Won-Chul, Lee Jeong Seok, Park Woo Chan, Kim Sung Hun, Choi Yoon-La, Lee Jeongmin, Ju Young Seok, Park Yeon Hee

Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data

利用真实世界数据和NATALEE数据,基于机器学习预测HR+/HER2-早期乳腺癌远处复发风险和瑞博西尼治疗效果

Howard, Frederick M; Fasching, Peter A; Santa-Maria, Cesar A; Lim, Elgene; Sparano, Joseph A; Lustberg, Maryam B; Bachelot, Thomas; Blyuss, Oleg; Brezden-Masley, Christine; Park, Yeon Hee; Akdere, Murat; Ye, Fen; Pantoja, Kristyn; Kurz, Christoph; Dominguez Castro, Patricia; Razavi, Pedram

DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer

DESTINY-Breast08:曲妥珠单抗德鲁替康联合其他抗癌疗法治疗HER2低表达转移性乳腺癌患者的Ib期研究

Jhaveri, Komal; Loi, Sherene; Hamilton, Erika; Schmid, Peter; Anders, Carey K; Testa, Laura; Wildiers, Hans; Tseng, Ling-Ming; Lu, Yen-Shen; Park, Yeon Hee; Im, Seock-Ah; Chen, Shin-Cheh; Young, Robyn R; Lloyd, Caron; Wrona, Magdalena; Zhang, Cuihong; Carroll, Danielle; André, Fabrice

Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer

乳腺癌女性持续性化疗诱发脱发的种族和民族差异

Kang, Danbee; Kraehenbuehl, Lukas; Lee, Haseen; Kim, Nayeon; Kim, Ji-Yeon; Park, Yeon Hee; Ahn, Hee-Kyung; Goldfarb, Shari B; Patil, Sujata; Lo Sicco, Kristen I; Shapiro, Jerry; Kearney, Caitlin A; Cho, Juhee; Lacouture, Mario E; Ahn, Jin Seok

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management

更正:第二部分:亚太地区BRCA相关乳腺癌的共识声明和专家建议:临床管理

Park, Yeon Hee; Lee, Soo Chin; Singer, Christian F; Balmaña, Judith; Dent, Rebecca Alexandra; Tan, Veronique Kiak-Mien; Mulansari, Nadia Ayu; Yusof, Mastura Md; Que, Frances Victoria F; Lu, Yen-Shen; Parinyanitikul, Napa; Pham, Cam Phuong; Taib, Nur Aishah; Kong, Sun-Young; Antill, Yoland; Kim, Hee Jeong

Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion

利用残余肿瘤负荷分级和淋巴血管侵犯对新辅助治疗后残留三阴性乳腺癌进行更精细的风险分层

Lee, Tae Hoon; Lee, Hyunwoo; Jang, Jeong Yun; Park, Won; Cho, Won Kyung; Cho, Eun Yoon; Ahn, Jin Seok; Park, Yeon Hee; Nam, Seok Jin; Kim, Seok Won; Lee, Jeong Eon; Kim, Haeyoung

Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer

止吐预防对减少 HER2+/HER2-低表达乳腺癌患者曲妥珠单抗德鲁替康剂量调整的影响

Shin, Junghoon; Kim, Ji-Yeon; Ahn, Hee Kyung; Ahn, Jin Seok; Park, Yeon Hee

Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)

一项针对绝经前淋巴结阳性早期乳腺癌低基因组风险患者的卵巢功能抑制内分泌治疗的前瞻性单臂研究(INTERSTELLAR试验,KBCSG-25)

Ahn, Sung Gwe; Sim, Sung Hoon; Kang, Taewoo; Kim, Eun-Kyu; Lee, Jeong Eon; Moon, Hyeong-Gon; Ahn, Jee Hyun; Lim, Woosung; Youn, Hyun Jo; Kim, Hyun-Ah; Yoon, Chang Ik; Kim, Jisun; Kang, Byeongju; Park, Min Ho; Kang, Su Hwan; Kim, Lee Su; Bae, Soong June; Kook, Yoonwon; Lee, Kwan Ho; Lee, Han-Byoel; Han, Wonshik; Park, Yeon Hee

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial

曲妥珠单抗德鲁替康治疗HER2低表达转移性乳腺癌:随机3期DESTINY-Breast04试验的长期生存分析

Modi, Shanu; Jacot, William; Iwata, Hiroji; Park, Yeon Hee; Vidal Losada, Maria; Li, Wei; Tsurutani, Junji; Ueno, Naoto T; Zaman, Khalil; Prat, Aleix; Papazisis, Konstantinos; Rugo, Hope S; Yamashita, Toshinari; Harbeck, Nadia; Im, Seock-Ah; De Laurentiis, Michelino; Pierga, Jean-Yves; Wang, Xiaojia; Gombos, Andrea; Tokunaga, Eriko; Orbegoso Aguilar, Cecilia; Yung, Lotus; Xiao, Feng; Cheng, Yingkai; Cameron, David

Pembrolizumab and chemotherapy in high-risk, early-stage, ER(+)/HER2(-) breast cancer: a randomized phase 3 trial

帕博利珠单抗联合化疗治疗高危早期ER(+)/HER2(-)乳腺癌:一项随机3期试验

Cardoso, Fatima; O'Shaughnessy, Joyce; Liu, Zhenzhen; McArthur, Heather; Schmid, Peter; Cortes, Javier; Harbeck, Nadia; Telli, Melinda L; Cescon, David W; Fasching, Peter A; Shao, Zhimin; Loirat, Delphine; Park, Yeon Hee; Fernandez, Manuel Gonzalez; Rubovszky, Gábor; Spring, Laura; Im, Seock-Ah; Hui, Rina; Takano, Toshimi; André, Fabrice; Yasojima, Hiroyuki; Ding, Yu; Jia, Liyi; Karantza, Vassiliki; Tryfonidis, Konstantinos; Bardia, Aditya